- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 209204, 8 pages
Diagnosis of Familial Wolf-Hirschhorn Syndrome due to a Paternal Cryptic Chromosomal Rearrangement by Conventional and Molecular Cytogenetic Techniques
1Servicio de Genética, Hospital General de México, Dr. Balmis No. 148, Colonia Doctores, 06726 México, DF, Mexico
2Facultad de Medicina, Universidad Nacional Autónoma de México, México, DF, Mexico
3Departamento de Medicina Genómica, Hospital General de México, Dr. Balmis No. 148, Colonia, Doctores, 06726 México, DF, Mexico
Received 26 October 2012; Accepted 13 December 2012
Academic Editor: Ozgur Cogulu
Copyright © 2013 Carlos A. Venegas-Vega et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The use of conventional cytogenetic techniques in combination with fluorescent in situ hybridization (FISH) and single-nucleotide polymorphism (SNP) microarrays is necessary for the identification of cryptic rearrangements in the diagnosis of chromosomal syndromes. We report two siblings, a boy of 9 years and 9 months of age and his 7-years- and 5-month-old sister, with the classic Wolf-Hirschhorn syndrome (WHS) phenotype. Using high-resolution GTG- and NOR-banding karyotypes, as well as FISH analysis, we characterized a pure 4p deletion in both sibs and a balanced rearrangement in their father, consisting in an insertion of 4p material within a nucleolar organizing region of chromosome 15. Copy number variant (CNV) analysis using SNP arrays showed that both siblings have a similar size of 4p deletion (~6.5 Mb). Our results strongly support the need for conventional cytogenetic and FISH analysis, as well as high-density microarray mapping for the optimal characterization of the genetic imbalance in patients with WHS; parents must always be studied for recognizing cryptic balanced chromosomal rearrangements for an adequate genetic counseling.
Current diagnosis of chromosomal syndromes should include a combination of conventional cytogenetic techniques with molecular cytogenetic methods, particularly fluorescent in situ hybridization (FISH), as well as modern genomic applications such as copy number variations (CNVs) analysis by single-nucleotide polymorphism (SNP) or comparative genomic hybridization (aCGH) microarray techniques. The laboratory methods employed to achieve an adequate diagnosis of a familial case of Wolf-Hirschhorn syndrome (WHS, OMIM194190) exemplifies how the conventional, molecular and genomic techniques are complementary and useful to provide an appropriate genetic counseling in chromosomal syndromes.
Wolf-Hirschhorn syndrome affects at least 1/50,000 newborns and presents a broad range of clinical manifestations. WHS is characterized by a typical craniofacial appearance, growth delay, mental retardation, hypotonia, and seizures . In the majority of cases (50–60%), WHS is caused by “pure” de novo terminal or interstitial deletions in 4p16; unbalanced translocations (45%), either de novo or inherited from a balanced rearrangement (~15%), and other complex cytogenetic findings (>1%) such as a chromosome 4 ring, del(4p) mosaicism, or a duplication/deletion rearrangement derived from a chromosome 4 inversion [2, 3] have been observed as well. In a high proportion of the WHS patients (25–30%), the chromosomal abnormality is cryptic and not detectable by conventional cytogenetic techniques. In cases of clinical suspicion of WHS in a patient with normal karyotype, additional FISH studies of the sub-telomeres and the WHS critical region (WHSCR) must be performed .
The high degree of variation in the clinical presentation of WHS has been attributed to differences in the size of the 4p deletion, the presence of a partial trisomy from the segregation of a chromosomal translocation or inversion, allelic differences or multifactorial inheritance [2–5]. The majority of familial cases have been associated with parental chromosomal balanced translocations, particularly t(4p; 8p), which represents a distinct genetic entity [2, 5, 6]. Chromosomes 7p, 11p, 12p, and Dp/Gp, have also frequently been implicated in 4p inherited or de novo rearrangements [2, 5, 7–10]. We describe two sibs with a classic WHS phenotype and 4p16.1-p16.3 deletions (~6.5 Mb) due to the segregation of a paternal balanced rearrangement, characterized by karyotyping, FISH, and microarray copy-number analysis.
2. Materials and Methods
2.1. Clinical Report
The family pedigree is shown in Figure 1. The parents were a healthy, young, non-consanguineous couple. II:1 is a healthy 11-year old girl. The propositus (II:2) is a 9 years and 9 months of age boy, born at 37.5 gestation weeks by cesarean section due to fetal distress; birth weight: 2,125 g, height 43 cm (both <3rd centile). Hypotonia was noted at birth. At 7 months of age, the patient developed generalized tonic-clonic seizures. Clinical examination at 9 years and 9 months of age revealed psychomotor retardation; height 124 cm, weight 15 kg, and OFC 45.3 (all <3rd centile). He displayed facial features typical of WHS (Figure 1(a)). Psychological examination by WISC-R revealed a global IQ of 25. II:4 is a 7-years and 5-month old girl, born at 37.2 weeks by cesarean section, birth weight 2,100 g and height 42 cm (both <3rd centile). She showed clinical findings similar to those of her brother (Figure 1(b)), and renal ultrasound reported left kidney malrotation. Her global IQ was 30. The clinical features of both patients are described in Table 1. Initial conventional cytogenetic analysis by GTG banding (400–700 bands) revealed a 4p16 deletion in both sibs, suggesting a parental chromosomal balanced rearrangement.
2.2. Cytogenetic and FISH Analysis
Chromosome analyses on lymphocytes by GTG (400–700 bands) and NOR banding were performed according to standard protocols. FISH was performed using LSI WHSCR1 Spectrum Orange and CEP 4 Spectrum Green probes and ToTelVysion Mixtures number 4 (4p Spectrum Green, 4q Spectrum Orange, 21q Spectrum Green/Orange, and LSI AML1 Spectrum Aqua) and number 10 (10p Spectrum Green, 10q Spectrum Red, 15q Spectrum Green/Orange and LSI PML Spectrum Aqua) from Vysis Abbot, Inc. (Abbot Park, IL, USA), according to the procedures described by the manufacturer.
2.3. Microarray Analysis
High purity genomic DNA was extracted from 3 mL whole blood using the Versagene DNA Purification kit (Gentra Systems Inc., Minneapolis, MN, USA). Genomic mapping was performed on the affected sibs and parents using the Genome-wide human SNP array 5.0 set (Affymetrix Inc., Santa Clara, CA, USA), according to the protocol supplied by the manufacturer. Genotyping Console 4.1 (Affymetrix Inc.) was used for quality assessment and genotyping of the data. The QC call rate by the BRLMM-P algorithm was over 93%. CNV analysis was performed using SNP & Variation Suite 7.5.6 software (Golden Helix Inc., Bozeman, MT, USA). Patients’ data were normalized against a reference set generated in our laboratory, consisting of 71 healthy subjects including the patients’ parents. The copy number analysis method (CNAM) was used to identify the CNV segments with a moving window of 10,000 markers in a univariate basis. Mapping was carried out based on the human genome assembly Feb 2009 (GRCh 37/hg19) (NCBI Reference Sequence (RefSeq) http://www.ncbi.nlm.nih.gov/RefSeq/).
3.1. Cytogenetic and FISH Analysis
High-resolution GTG banding on the affected children revealed a 4p16.1 deletion (Figures 2(a) and 2(b)). FISH using WHSCR1 and 4p subtelomeric probes confirmed the loss of both sequences (Figures 2(g) and 2(h)). The mother’s karyotype was normal, while the phenotypically normal father carries a derivative chromosome 4 and an apparent heteromorphism in both chromosomes 15 (Figure 2(c)). FISH using ToTelVysion Mixtures 4 and 10 showed that 4p subtelomeric signal was located on the short arm of one chromosome 15 (Figure 2(i)). Ag-NOR banding was negative on 4p, and no association of der(4) with acrocentric chromosomes was observed; der(15) was positive for Ag-NOR and acrocentric association (Figures 2(d), 2(e) and 2(f)) confirming an insertion from 4p to 15p. The other chromosome 15 showed an increased stalk on its short arms (Figures 2(e) and 2(f)). Both affected children inherited this chromosome 15pstk+ (Figures 2(a) and 2(b)). The father’s final karyotype was 46,XY,ins(15;4)(p12;p16.1p16.3).ish ins(15; 4) (D4S3359+,PML+,D15S936+; D4S3359-,D4S2930+). II: 1 inherited the same balanced rearrangement from her father (data not shown).
3.2. Microarray Analysis
CNV analysis confirmed a similar 4p deletion in both siblings, 6.48 Mb in the propositus, and 6.50 Mb in his affected sister. The minimal deletion positions were from nt.69,535 to 6,546,304 and from nt.58,388 to 6,560,313, respectively (Figure 3(a)). These include WHSCR and WHSCR2. The telomeric break points affected the ZNF718 and ZNF595 genes in both sibs; however an 11.1 Kb difference was observed between these (Figure 3(b)). The distal region of 4p is highly variable (database of Genomic Variants http://projects.tcag.ca/variation/), and the children inherited a different chromosome 4 from their mother, as documented by the SNP genotyping analysis (data not shown). The centromeric break point differs by 14 Kb between sibs, and in both cases the gene MAN2B2 maps outside the deletion, at least 15.2 Kb from its start point (Figure 3(c)). Acrocentric p arms are not represented in the 5.0 SNP array.
Three clinical categories of WHS have been defined according to the size of the 4p deletion: (1) <3.5 Mb, linked to a mild form, (2) between 5 and 18 Mb, associated with the classical phenotype observed in our patients, and (3) >22 Mb, causing a severe form . The pathogenesis of WHS is multigenic, and genotype-phenotype correlation studies may clarify the role of specific genes on 4p in the disease etiology [2, 4]. CNV analysis in our patients revealed a similar 4p deletion of ~6.5 Mb, with the common deleted segment spanning from 69,535 Kb to 6,546,304 Mb, that is, 4p16.1 to 4p16.3 (Figure 3(a)). The deletion affects at least 70 genes, including the 200 kb critical region for the typical WHS phenotype , and the candidate genes LETM1, FGFRL1 and WHSC1, which have been associated with seizures, some facial findings, distinctive facial features and growth delay, respectively [4, 12]. The genes ATP5I, FGFR3, HTT, MSX1 and PPP2R2C are likely haploinsufficient (Decipher database http://decipher.sanger.ac.uk), and could also be relevant to the WHS phenotype.
Different types of chromosomal rearrangements are associated with WHS; among these, inherited unbalanced translocations are frequently maternal, while de novo unbalanced translocations are usually paternal, with the exception of the t(4;8) [2, 5, 13]. In our patients, we identified an isolated 4p deletion due to a paternal balanced insertion (Figure 4). To our knowledge, this rearrangement has not been previously reported in WHS.
Recently, it has been suggested that chromosomal insertions are more frequent (1 : 500) [14–16] than previously reported (1 : 80000) . These rearrangements involve three chromosome breakage events that can be intra- or interchromosomal. The use of FISH to confirm deletions and/or duplications detected by microarrays showed that these genomic imbalances resulted from the segregation of a parentally balanced insertion [14, 15]. Interestingly, the short arms of acrocentric chromosomes are frequently involved in these rearrangements, especially the NOR of chromosomes 15 and 22, and they are often cryptic when present in an unbalanced form . Genomic studies have demonstrated that different gene families and certain satellite repeats, like the olfactory receptor gene family and the terminal 4p repeats, constitute nucleolus-associated chromatin domains that interact with the satellite repeats and rDNA of acrocentric chromosomes [18, 19]. This could explain the high frequency of acrocentric chromosomal rearrangements with different partners. Recently some WHS rearrangements have been recognized to involve a translocation between the NOR of an acrocentric chromosome and chromosome 4, producing a satellited 4p chromosome. Some of these cases are sporadic and other familial [2, 7, 10, 20]. Our patients are the product of an adjacent I segregation from the paternal insertion, and the nonaffected girl received both derivative chromosomes by alternate segregation (Figure 4). Wu et al.  reported a family with coexisting sibs, which are the products of both types of gametes from an adjacent I segregation: one with a 4p deletion of 5 Mb and classical WHS and the other with a pure duplication of the same region of 4p.
Only few cases of familiar recurrence of WHS have been described and they are usually associated with a balanced chromosomal translocation in one parent. Nevertheless, the WHS phenotype is modified by the trisomy of other chromosomal region [5, 13, 21, 22]. One instance of a familial recurrence of a 4p pure deletion was due to a meiotic amplification of a maternal 1.5 Mb deletion. The mother had mild WHS, while her two affected sons displayed a typical phenotype. One of the sons was studied and revealed a 2.8 Mb deletion . Another case of two sibs showing a mild form of WHS were reported to have a pure 4p deletion of 2.8 Mb, from a mother with a karyotype 46,XX,t(4;14)(p16.3;p12) . Our patients also have a pure 4p terminal deletion of 6.5 Mb associated with classical WHS phenotype due to a father ins(15;4)(p12;p16.1p16.3); however, only minor phenotype differences were observed between sibs in both families. The differences in the severity of the phenotypes in these two familiar cases could be result of the size of the chromosomal deleted region as has been suggested .
The small difference in the size of the deleted material, 25 Kb, among our propositus and his affected sister could be attributed to a maternal polymorphism, recombination aneusomy, or microarray data normalization. The most striking clinical differences between sibs were the type of cardiac defect, the presence of downslanting palpebral fissures and ptosis only in the boy, and kidney malrotation present only in the girl. Comparing the clinical data of our patients with the data reported by Zollino et al.  in patients with classical WHS phenotype and deletions between 5 and 18 Mb (Table 1), the only major differences were the absence of ocular coloboma and hypospadias. Until now, few WHS patients had been studied by genomic high-resolution methods [1, 2, 4, 10, 14, 20]. As the number of these studies increases, a better determination of the exact size of deletions will be achieved, improving the definition of the regions and genes implicated in each phenotypic trait associated with the classical WHS.
The clinical variability in our classical WHS patients could be explained by polymorphisms in the 4p alleles present plus multifactorial inheritance patterns.
Our results reinforce the importance of thorough clinical diagnosis, as well as conventional and molecular karyotyping of patients and their parents for proper genetic diagnosis and counseling. Particularly, the use of high-density SNP arrays for CNV analysis in the patients enables the determination of the size of the deletion with higher precision and can detect cryptic partial trisomies. In order to give an adequate genetic counseling, the parents of a child with a 4p deletion should always be studied by FISH with subtelomeric 4p and WHSCR1 specific probes, to corroborate if they are carriers of a cryptic balanced rearrangement. In conclusion, we identified a novel type of chromosome rearrangement involved in sibs recurrent classical WHS, and its mechanism is apparently more frequent than previously thought. This case demonstrates the importance of the combined application of classical and molecular techniques to clarify chromosomal structural rearrangements.
Conflict of Interest
The authors declare no conflict of interests and state that none of them have any financial relation with the commercial identities mentioned in this work.
The authors thank the family for their participation in the study and CONACyT (2006-C01-13947).
- A. Battaglia, T. Filippi, and J. C. Carey, “Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision,” American Journal of Medical Genetics C, vol. 148, no. 4, pp. 246–251, 2008.
- S. T. South, H. Whitby, A. Battaglia, J. C. Carey, and A. R. Brothman, “Comprehensive analysis of Wolf-Hirschhorn syndrome using array CGH indicates a high prevalence of translocations,” European Journal of Human Genetics, vol. 16, no. 1, pp. 45–52, 2008.
- A. Battaglia, J. C. Carey, S. T. South, and T. J. Wright, “Wolf Hirschhorn syndrome,” in GeneReviews [Internet], R. A. Pagon, T. D. Bird, C. R. Dolan, and K. Stephens, Eds., Seattle University of Washington, Seattle, Wash, USA, 2007.
- N. M. C. Maas, G. Van Buggenhout, F. Hannes, et al., “Genotype–phenotype correlation in 21 patients with Wolf–Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH),” Journal of Medical Genetics, vol. 45, no. 2, pp. 71–80, 2008.
- M. Zollino, M. Murdolo, G. Marangi et al., “On the nosology and pathogenesis of Wolf-Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review,” American Journal of Medical Genetics C, vol. 148, no. 4, pp. 257–269, 2008.
- D. Wieczorek, M. Krause, F. Majewski et al., “Unexpected high frequency of de novo unbalanced translocations in patients with Wolf-Hirschhorn syndrome (WHS) ,” Journal of Medical Genetics, vol. 37, no. 10, pp. 798–804, 2000.
- J. B. Ravnan, J. H. Tepperberg, P. Papenhausen et al., “Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities,” Journal of Medical Genetics, vol. 43, no. 6, pp. 478–489, 2006.
- S. T. South, H. Whitby, T. Maxwell, E. Aston, A. R. Brothman, and J. C. Carey, “Co-occurrence of 4p16.3 deletions with both paternal and maternal duplications of 11p15: modification of the Wolf-Hirschhorn syndrome phenotype by genetic alterations predicted to result in either a Beckwith-Wiedemann or Russell-Silver phenotype,” American Journal of Medical Genetics A, vol. 146, no. 20, pp. 2691–2697, 2008.
- Z. Ou, P. Stankiewicz, Z. Xia et al., “Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes,” Genome Research, vol. 21, no. 1, pp. 33–46, 2011.
- L. Wu, D. Meng, Z. Zhou, J. Du, Z. Long, and D. Liang, “A family with partial duplication/deletion 4p due to a balanced t (4; 15) (p16.2; p11.2) translocation,” American Journal of Medical Genetics A, vol. 155, no. 3, pp. 656–659, 2011.
- M. Zollino, R. Lecce, R. Fischetto et al., “Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2,” American Journal of Human Genetics, vol. 72, no. 3, pp. 590–597, 2003.
- H. Engbers, J. J. van der Smagt, R. van't Slot, J. R. Vermeesch, R. Hochstenbach, and M. Poot, “Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions,” European Journal of Human Genetics, vol. 17, no. 1, pp. 129–132, 2009.
- M. Zollino, R. Lecce, A. Selicorni et al., “A double cryptic chromosome imbalance is an important factor to explain phenotypic variability in Wolf-Hirschhorn syndrome,” European Journal of Human Genetics, vol. 12, no. 10, pp. 797–804, 2004.
- S. H. L. Kang, C. Shaw, Z. Ou et al., “Insertional translocation detected using FISH confirmation of array-comparative genomic hybridization (aCGH) results,” American Journal of Medical Genetics A, vol. 152, no. 5, pp. 1111–1126, 2010.
- N. J. Neill, B. C. Ballif, A. N. Lamb et al., “Recurrence, submicroscopic complexity, and potential clinical relevance of copy gains detected by array CGH that are shown to be unbalanced insertions by FISH,” Genome Research, vol. 21, no. 4, pp. 535–544, 2011.
- B. A. Nowakowska, N. de Leeuw, C. A. Ruivenkamp, et al., “Parental insertional balanced translocations are an important cause of apparently de novo CNVs in patients with developmental anomalies,” European Journal of Human Genetics, vol. 20, no. 2, pp. 166–170, 2012.
- J. O. Van Hemel and H. J. Eussen, “Interchromosomal insertions: identification of five cases and a review,” Human Genetics, vol. 107, no. 5, pp. 415–432, 2000.
- A. Nmeth, A. Conesa, J. Santoyo-Lopez, et al., “Initial genomics of the human nucleolus,” PloS Genetics, vol. 6, no. 3, article e1000899, 2010.
- S. Van Koningsbruggen, M. Gierliński, P. Schofield et al., “High-resolution whole-genome sequencing reveals that specific chromatin domains from most human chromosomes associate with nucleoli,” Molecular Biology of the Cell, vol. 21, no. 21, pp. 3735–3748, 2010.
- D. Liang, Z. Zhou, D. Meng, et al., “Three patients with Wolf-Hirschhorn syndrome carrying a satellited chromosome 4p,” Birth Defects Research A, vol. 94, no. 7, pp. 549–552, 2012.
- J. Goodship, A. Curtis, I. Cross et al., “A submicroscopic translocation, t(4;10), responsible for recurrent Wolf-Hirschhorn syndrome identified by allele loss and fluorescent in situ hybridisation,” Journal of Medical Genetics, vol. 29, no. 7, pp. 451–454, 1992.
- E. Reid, N. Morrison, L. Barron et al., “Familial Wolf-Hirschhorn syndrome resulting from a cryptic translocation: a clinical and molecular study,” Journal of Medical Genetics, vol. 33, no. 3, pp. 197–202, 1996.
- F. Faravelli, M. Murdolo, G. Marangi, F. D. Bricarelli, M. D. Rocco, and M. Zollino, “Mother to son amplification of a small subtelomeric deletion: a new mechanism of familial recurrence in microdeletion syndromes,” American Journal of Medical Genetics A, vol. 143, no. 11, pp. 1169–1173, 2007.